BSTK yields 15384.62% · PFE yields 6.13%● Live data
📍 BSTK pulled ahead of the other in Year 1
Combined, BSTK + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BSTK + PFE for your $10,000?
Brite-Strike Tactical Illumination Products, Inc. designs and manufactures tactical lighting products and solutions for the military, law enforcement, hunting, camping, outdoor recreation, and marine safety markets in the United States. The company provides Tactical Blue Dot series products, perimeter infrared intrusion security alert products, adhesive light strips, remote pressure switches, rolling illuminated distraction and disorientation devices, baton integrated lights, duty light cameras, basic tactical lights, observation cameras, police cycle and traffic safety gloves, executive precision lighting instruments, and helmet light attachment systems, as well as accessories, such as holsters, color lenses, and batteries. It also offers outdoor adventure and recreation products, including rechargeable lighted dog collars and leashes, adhesive light strips, outdoor adventure signal safety packs, camp alert perimeter security and survival signaling systems, and sport gloves; and citizens safety products comprising personal protection systems, personal alarms, and anodized aluminum LED multi-tools, as well as tactical flashlight instructor courses. The company is based in Plymouth, Massachusetts.
Full BSTK Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.